LRCX — Lam Research Income Statement
0.000.00%
- $126.75bn
- $124.85bn
- $18.44bn
- 100
- 29
- 95
- 88
Annual income statement for Lam Research, fiscal year end - June 29th, USD millions except per share, conversion factor applied.
2021 June 27th | 2022 June 26th | 2023 June 25th | 2024 June 30th | 2025 June 29th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14,626 | 17,227 | 17,429 | 14,905 | 18,436 |
Cost of Revenue | |||||
Gross Profit | 6,805 | 7,872 | 7,855 | 7,096 | 8,979 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10,144 | 11,845 | 12,254 | 10,641 | 12,535 |
Operating Profit | 4,482 | 5,382 | 5,175 | 4,264 | 5,901 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,371 | 5,193 | 5,109 | 4,360 | 5,958 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,908 | 4,605 | 4,511 | 3,828 | 5,358 |
Net Income Before Extraordinary Items | |||||
Net Income | 3,908 | 4,605 | 4,511 | 3,828 | 5,358 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,908 | 4,605 | 4,511 | 3,828 | 5,358 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.69 | 3.27 | 3.4 | 2.94 | 4.15 |
Dividends per Share |